Macrogenics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.06

+0.32 (+8.56%)

As of Sep 28, 10:21 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 64%

Hold 5 36%

Sell 0 0%

Price Target

Analyst Price Target +980.0% upside

Low Target $27.62

Average Target $43.85

High Target $64.74

Current Price $4.06

Current
$4.06

Target
$43.85

$27.62 $43.85 avg $64.74

Scenario Analysis

Bear Case

$27.62

580.3%

Low target

Base Case

$43.85

+980.0%

Avg target

Bull Case

$64.74

+1,494.6%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$5.08

-20.1% from high

52-Week Low

$1.29

+214.7% from low

Target vs 52W High

$43.85

+763.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%